Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1/2 4Phase 1 3Phase 4 1Phase 3 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Breast 2Thoracic 1Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Renal Cell 13Sarcoma 10Neoplasms 10Breast Neoplasms 8Neoplasm Metastasis 7Carcinoma, Non-Small-Cell Lung 5Ovarian Neoplasms 3Colorectal Neoplasms 3Advanced Cancers 3Thyroid Neoplasms 2Solid Tumors 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Lung Neoplasms 2Liver Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Wilms Tumor 1Unspecified Adult Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor - Protocol Specific 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumours 1Solid Neoplasm 1Recurrence 1Osteosarcoma 1Optic Nerve Glioma 1Neuroblastoma 1Lymphoma 1

Interventions

Paclitaxel 68Carboplatin 64pembrolizumab 32Cyclophosphamide 32Bevacizumab 27liposomal doxorubicin 24Cisplatin 24Topotecan 21Gemcitabine 21olaparib 18fludarabine 17Taxes 16Docetaxel 15Nivolumab 14Doxorubicin 14niraparib 13veliparib 12Albumin-Bound Paclitaxel 11aldesleukin 9Filgrastim 9fludarabine phosphate 8durvalumab 8Oxaliplatin 8Fluorouracil 8Drug Therapy 8sargramostim 7Peripheral Blood Stem Cell Transplantation 7Magnetic Resonance Spectroscopy 7Leucovorin 7talazoparib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Ovarian Neoplasms × pazopanib × Clear all
NCT02009449 2024-11-15

IVY

Eli Lilly and Company

Phase 1 Completed
353 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00722293 2017-11-13

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

GlaxoSmithKline

Phase 1 Completed
111 enrolled
BreastGynecologicSarcoma

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Sarcoma

NCT01608009 2017-03-10

PAZPET-1

Imperial College London

Phase 1 Completed
16 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡